当前位置:首页 >财报库 > 报告详情

史赛克Stryker Corporation(SYK)2025年第二季度财报(10-Q)「NYSE」(英文版)(23页).pdf

上传人: 1****1 编号:1002327 2025-09-26 23页 1.50MB

下载:

1、 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended June 30,2025 ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934Com

2、mission file number:001-13149 STRYKER CORPORATION(Exact name of registrant as specified in its charter)Michigan38-1239739(State of incorporation)(I.R.S.Employer Identification No.)1941 Stryker Way Portage,Michigan49002(Address of principal executive offices)(Zip Code)(269)385-2600(Registrants teleph

3、one number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock,$.10 Par ValueSYKNew York Stock Exchange2.125%Notes due 2027SYK27New York Stock Exchange3.375%Notes due 2028SYK28New York

4、 Stock Exchange0.750%Notes due 2029SYK29New York Stock Exchange2.625%Notes due 2030SYK30New York Stock Exchange1.000%Notes due 2031SYK31New York Stock Exchange3.375%Notes due 2032SYK32New York Stock Exchange3.625%Notes due 2036SYK36New York Stock ExchangeIndicate by check mark whether the registrant

5、(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No I

6、ndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was required to submit such file

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据报告的内容,以下是全文主要内容的概括: 1. Stryker在2025年第二季度实现了11.1%的销售增长,调整后净利润增长11.4%,达到每股3.13美元。上半年销售增长11.5%,调整后净利润增长12.4%,达到每股5.97美元。 2. MedSurg和Neurotechnology部门销售增长17.3%,而Orthopaedics部门销售增长2.0%。美国销售增长12.5%,国际销售增长6.8%。 3. 研发费用占销售额的6.8%,销售和管理费用占销售额的34.5%,均较上年有所增长。运营利润率从上年同期的19.4%下降至18.5%。 4. 有效税率从上年同期的17.3%下降至13.0%,主要受脊髓植入物业务出售的税收影响。 5. Stryker在2025年2月完成了对Inari的收购,并发行了新的债务。
**季度业绩如何?** **Stryker增长动力何在?** **财务状况揭秘**
客服
商务合作
小程序
服务号
折叠